VAISHALI8.59

Vaishali Pharma Limited

· Unclassified
₹ CrorePeersTEMBOTOTALOSWALSEEDSGROBTEABEARDSELLHINDCONCROWNARTNIRMANMcap ₹56 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
VAISHALI
FY26
TEMBO
FY26
TOTAL
FY26
OSWALSEEDS
FY26
Peer
Median
Valuation — at last close
P/E26.84×1.03×14.56×18.53×14.56× +84%
P/B0.81×0.21×1.25×2.62×1.25× -35%
EV/EBITDA17.86×2.61×9.69×13.39×9.69× +84%
Market Cap₹56 Cr₹106 Cr₹113 Cr₹134 Cr₹113 Cr -51%
Growth
Revenue CAGR 3Y63.42%1.74%-3.04%1.74%
Revenue CAGR 5Y59.59%14.57%37.08%
Net Income CAGR 3Y156.94%14.52%8.17%14.52%
Revenue YoY (latest Q)21.86%31.29%19.54%21.86%
Net Income YoY (latest Q)61.25%40.45%68.59%61.25%
Profitability
EBITDA Margin3.78%13.07%2.40%5.85%5.85% -35%
Net Income Margin3.83%9.01%1.27%2.91%2.91% +32%
Return on Common Equity6.03%18.57%8.61%14.15%14.15% -57%
Return on Capital Employed4.68%18.42%10.98%25.82%18.42% -75%
Return on Assets3.38%7.52%4.12%5.14%5.14% -34%
Credit & Quality
Total Debt/Equity0.27×0.77×0.42×1.21×0.77× -65%
Interest Coverage1.79×5.43×2.79×3.01×3.01× -41%
Scale — latest FY
Revenue / Total Income₹109 Cr₹1,090 Cr₹622 Cr₹248 Cr₹622 Cr -83%
Net Income₹4.2 Cr₹98.2 Cr₹7.9 Cr₹7.2 Cr₹7.9 Cr -47%
Total Assets₹123 Cr₹1,306 Cr₹191 Cr₹141 Cr₹191 Cr -35%
EPS₹0.32₹55.11₹4.83₹0.79₹4.83 -93%
Book Value per Share₹10.6₹265.21₹56.13₹5.58₹56.13 -81%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.